Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease
- PMID: 20167961
Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease
Abstract
An HIV-positive man from Somalia presented with severe malaise, weight loss, relapsing fever, lymphadenopathy and splenomegaly. An FDG-PET-scan-guided lymph node biopsy revealed the characteristic histological features of the plasma cell variant of Castleman's disease. A high HHV-8 viral load was detected in the serum (7980 copies/ml). Treatment with HAART, rituximab and vinblastine resulted in a full and rapid recovery and lowered HHV-8 viral load to undetectable levels.
Similar articles
-
Multicentric Castleman's disease & HIV infection.Ir Med J. 2009 Oct;102(9):294-5. Ir Med J. 2009. PMID: 19902650
-
Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.J Med Virol. 2009 May;81(5):888-96. doi: 10.1002/jmv.21349. J Med Virol. 2009. PMID: 19319955
-
Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease.Eur J Haematol. 2006 Mar;76(3):269-71. doi: 10.1111/j.0902-4441.2005.t01-1-EJH2435.x. Eur J Haematol. 2006. PMID: 16451402
-
HIV-associated multicentric Castleman's disease.Am J Hematol. 2008 Jun;83(6):498-503. doi: 10.1002/ajh.21137. Am J Hematol. 2008. PMID: 18260115 Review.
-
Multicentric Castleman's disease in HIV infection.Int J STD AIDS. 2006 Jan;17(1):19-24; quiz 25. doi: 10.1258/095646206775220496. Int J STD AIDS. 2006. PMID: 16409673 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical